This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Carey RM. The intrarenal renin-angiotensin system in hypertension. Adv Chronic Kidney Dis 2015; 22:204.Search in Google Scholar
Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001; 345:1689.Search in Google Scholar
Dzau VJ, Colucci WS, Williams GH, et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 1980; 302:1373.Search in Google Scholar
Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327:669.Search in Google Scholar
Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851.Search in Google Scholar
Rigatto C, Parfrey P, Foley R, et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13:1084.Search in Google Scholar
Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145.Search in Google Scholar
Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861.Search in Google Scholar
Anderson S, Renke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in therat. J Clin Invest 1986; 1993-2000.Search in Google Scholar
Price DA, Porter LE, Gordon M.The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999; 10:2382-2391.Search in Google Scholar
Lewis EJ et al. The effect of angiotensin-converting -enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329:1456-1462.Search in Google Scholar
Maschio G, Alberti D. Effect of yje angiotensin-converting-enzyme inhibitor benazepril on progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334:939-945.Search in Google Scholar
Ruggenenti P, Perna A, Gherardi G et al. Renoprotective proprieties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354:359-364.Search in Google Scholar
Effects of Ramipril on cardiovascular and micro-vascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub study. Heartly Outcomes Prevention. Evaluation Study Investigators. Lancet 2000; 355:253-259.Search in Google Scholar
Redgrave J, Rabinowe S, Hollenberg NK, Williams GH. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest 1985; 75:1285.Search in Google Scholar
Schunkert H, Ingelfinger JR, Hirsch AT, et al. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90:1523.Search in Google Scholar
Price DA, Fisher ND, Osei SY, et al. Renal perfusion and function in healthy African Americans. Kidney Int 2001; 59:1037.Search in Google Scholar
Fisher ND, Price DA, Litchfield WR, et al. Renal response to captopril reflects state of local renin system in healthy humans. Kidney Int 1999; 56:635.Search in Google Scholar
Price DA, Porter LE, Gordon M, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999; 10:2382.Search in Google Scholar
Freeman RH, Davis JO, Villarreal D. Role of renal prostaglandins in the control of renin release. Circ Res 1984; 54:1.Search in Google Scholar
Stahl RA, Paravicini M, Schollmeyer P. Angiotensin II stimulation of prostaglandin E2 and 6-keto-F1 alpha formation by isolated human glomeruli. Kidney Int 1984; 26:30.Search in Google Scholar
Oliver JA, Pinto J, Sciacca RR, Cannon PJ. Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog. J Clin Invest 1980; 66:748.Search in Google Scholar
Data JL, Gerber JG, Crump WJ, et al. The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res 1978; 42:454.Search in Google Scholar
Kumar R, Thomas CM, Yong QC, et al. The intracrine renin-angiotensin system. Clin Sci (Lond) 2012; 123:273.Search in Google Scholar
Weidmann P, Scheiner M.Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy; an update meta-analysis. Nephrpl Dial Transoalnt 1995; 10 (Suppl 9): S39-S426.Search in Google Scholar
Gilbert RE, Wu LL, Kelly DJ ei al.Patholpgical expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy.Implications for the pathogenesis of tubule -inyerstitial fibrosis. Am J Pathol 1999; 155: 429-440.Search in Google Scholar
